The National Institute for Occupational Safety and Health (NIOSH), which was PExA’s first customer in the United States, has placed an order for an upgrade of their PExA 2.0 instrument. The U.S. federal agency NIOSH, which conducts research and provides recommendations to prevent work-related injuries and illnesses, has ordered an update of their existing PExA…
Read morePExA AB (publ) (“PExA” or “the Company”) announces that one of the scientific papers based on results from the use of PExA’s technology has won an award at the European Respiratory Society (ERS) congress in Vienna. The award winner, Jeong-Lim Kim, a researcher at the Department of Occupational and Environmental Medicine at the Sahlgrenska Academy,…
Read morePExA AB (publ) (“PExA” or the “Company”) is participating for the second consecutive year at the European Respiratory Society (ERS) congress, one of the world’s largest congresses in respiratory medicine, held this year in Vienna. Five scientific papers, which include results based on the use of PExA’s technology, have been accepted for presentation at the…
Read morePExA AB has received trademark protection for the name PExA® within the European Union. PExA AB, which has developed world-unique research instruments for collecting biological samples from the small airways, is pleased to announce that the company has had the trademark PExA® approved and registered within the European Union. PExA, which is an acronym for…
Read moreThis is a Google translated news text! In a recently published review article, University Hospital and University of Southampton researchers evaluate PExA’s technology by summarizing the results of a number of previously published studies based on samples from PExA and other comparable methods. In the article, the researchers describe, among other things, how acute and…
Read more
